Cancer-causing gene discovery suggests new therapies

January 26, 2009

Scientists have discovered a novel way by which a much-studied cancer-promoting gene accelerates the disease. The finding suggests a new strategy to halt cancer's progress.

Up to now, research has largely focused on how the mutated gene, Myc, disrupts the ability of DNA to be "transcribed" into RNA - the first step in making proteins that are essential for cell growth and function. But the new research shows that this altered Myc gene, called an oncogene, can also act directly on the final stage of protein production.

The finding in mice suggests that drugs already available to counter this increased protein production could slow or stop cancer's runaway growth induced by Myc. Rapamycin, for example, an immunosuppressant drug already in clinical trials for cancer, might help treat cancers where Myc is over active, the scientists suggest.

The discovery was led by Davide Ruggero, PhD, and Maria Barna, PhD, faculty scientists at the University of California San Francisco (UCSF).

Study findings were published in the journal "Nature" (December 18, 2008).

"Control of protein production rapidly affects cell behavior, and in a robust manner," explains Ruggero, assistant professor of urology at the UCSF Helen Diller Family Comprehensive Cancer Center and co-senior author on the paper with Barna. "The ability of the Myc oncogene to directly alter this process may well explain the rapid progression of cancer formation."

Scientists have known for some time that when the Myc gene is mutated and becomes an oncogene, it interferes with the early steps in DNA activity in the cell nucleus. But how the oncogene affected the subsequent production of proteins, a step known as translation, was unknown.

"A cancer causing gene, such as Myc, regulates many distinct cellular processes, and that can make it very difficult to tease apart which ones are the most important for the cancer to progress," says Barna, a faculty fellow in the UCSF biochemistry and biophysics department. "The key to our studies was the ability to generate novel genetic tools to halt Myc's action on protein production. This demonstrates how essential this process is for cancer formation."

To test whether protein production induced by Myc played a role in cancer, the UCSF- led team genetically crossed two types of mice: one that was cancer-prone and overexpressed the Myc oncogene and one that was newly engineered to lower protein production. The new cross of mice possessed not only the well-known destructive Myc traits, but also an enhanced ability to damp down protein production.

In these mice, the restrained protein production restored to near-normal the cell growth, division and protective cell-sacrifice needed to counter cancer.

The scientists also found that this increased control over the so-called "translation" of RNA into proteins countered damage to chromosome function otherwise caused by Myc, and preserved functions vital to faithful cell division. Changes in the genetic integrity of cells are recognized as hallmarks of cancer, and the new findings show that Myc can cause these abnormalities through control of protein production.

The research suggests that Myc may disrupt a number of genes "downstream" of its damage to DNA, the scientists say.

"We discovered a previously unrecognized link between alterations in protein synthesis and the mechanism by which cells maintain the integrity of the genome," Ruggero stresses. "We found that when Myc is overexpressed, this leads to changes in protein levels of a key gene that is essential for normal distribution of genetic material between daughter cells during cell division."

The findings are a positive step, he emphasizes, because they suggest that halting Myc's action on protein production with targeted therapies could prevent harmful genetic changes in cells that lead to cancer progression.

Co-authors with Ruggero and Barna are Aya Pusic, BS, scientific research assistant; Ornella Zollo,PhD, and Maria Costa, PhD, postdoctoral fellows, and Nadya Kondrashov, BA, all at UCSF; Eduardo Rego at the Center for Cell Based Therapy, Fundacao Hemocentro de Rebeiaro Preto, Sao Paulo, Brazil; and Pulivarthi Rao in the Department of Pediatrics, Baylor College of Medicine.

The research was funded by the National institutes of Health and the Sandler Foundation.

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.

The University of California, San Francisco

---

---

	North Carolina instructor uncovers cancer-causing gene.(faculty lounge): An article from: Community College Week by Cox, Matthews & Associates (Publisher) This digital document is an article from Community College Week, published by Cox, Matthews & Associates on October 25, 2004. The length of the article is 624 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: North Carolina instructor uncovers cancer-causing gene.(faculty lounge) Publication: Community College Week (Newspaper) Date: October 25, 2004 Publisher: Cox, Matthews & Associates Volume: 17 Issue: 6 Page: 16(1) Distributed by Thomson...
	Breakthrough: The Race to Find the Breast Cancer Gene by Kevin Davies (Author), Michael White (Author) September 1994. "The most impassioned and publicly visible of all genetic races" (The New York Times) comes to a triumphant close with the discovery of BRCA1, popularly known as the breast cancer gene. The result of a four-year international effort involving scientists from the United States, Canada, England, France, and Japan, among others, it is hailed as one of the most significant discoveries in recent medical science.Breakthrough is the brilliant account of this historic undertaking, its origins and development, and its implications for the future. With vivid profiles of the people and politics behind the events, Kevin Davies and Michael White unfold a scientific detective story that offers a rare glimpse into the complex—and fiercely competitive—world of genetic research. The...
	One Renegade Cell: How Cancer Begins (Science Masters Series) by Robert A. Weinberg (Author) One of the leading cancer researchers in the world, Robert A. Weinberg is perfectly suited to describe the search for cancer's origins from the early days of this century to the present. Presuming little knowledge of biology, he tells how a cancer-causing virus was first discovered in 1909, how the correlation was made between chemical carcinogens and cancer, and how oncogenes (the genes that can turn a cell malignant) work. He explains clearly how malignant cells send messages to one another and also block the messages of normal cells. Finally, Weinberg predicts that cancer prevention may depend on our ability to understand the mysterious chemical clock that regulates our cells' most basic functions. One Renegade Cell offers a concise, accessible route into the complex and often daunting...
	Defeat Cancer: 15 Doctors of Integrative & Naturopathic Medicine Tell You How by Connie Strasheim (Author), 13 Cancer Doctors (Author), Richard Linchitz MD (Introduction), Robert Rowen MD (Introduction) ONE-ON-ONE WITH 15 CANCER DOCTORS: If you traveled the world for appointments with fifteen cancer doctors, you would discover many of the cutting-edge treatments used to heal the body from cancer. You would also spend thousands of dollars on hotels, plane tickets, and medical appointment fees-not to mention the time that it would take to embark on such a journey. Even if you had the time and money to travel, would the physicians have enough time to answer all of your questions? Would you even know which questions to ask? In this long-awaited book, health care journalist Connie Strasheim has done all the work for you. She conducted intensive interviews with fifteen highly regarded doctors who specialize in cancer treatment, asking them thoughtful, important...
	Fighting Cancer with Vitamins and Antioxidants by Kedar N. Prasad Ph.D. (Author), K. Che Prasad M.S. M.D. (Author) The most up-to-date and complete resource on the powerful benefits of micronutrients for cancer treatment and prevention • Written by the nation’s leading expert on vitamins and cancer research • Reveals how to maximize the benefits of your cancer treatment program while minimizing the side effects of chemotherapy and radiation • Shows how to counteract the carcinogenic effects of dental X-rays, CT scans, mammograms, cell phones, and other unavoidable hazards of modern life • Provides an easy-to-follow program of nutritional supplements to improve your odds of avoiding and beating cancer Despite extensive research and the development of new treatments and drugs, the U.S. mortality rate from cancer has not changed...
	Essiac: A Native Herbal Cancer Remedy by Cythia Olsen (Author), Jim Chan (Contributor), Christopher Gussa (Contributor) This book gives a complete account of the recipe, the doses and of Essiac's uses now available through health food stores. Tells of experience of patients who have attained relief or regeneration from this remarkable herbal preparation.
	Never Be Sick Again: Health Is a Choice, Learn How to Choose It by Raymond Francis (Author), Kester Cotton (Collaborator) One day Raymond Francis, a chemist and a graduate of MIT, found himself in a hospital, battling for his life. The diagnosis: acute chemical hepatitis, chronic fatigue, multiple chemical sensitivities, and several autoimmune syndromes, causing him to suffer fatigue, dizziness, impaired memory, heart palpitations, diarrhea, numbness, seizures and numerous other ailments. Knowing death was imminent unless he took action, Francis decided to research solutions for his disease himself. His findings and eventual recovery led him to conclude that almost all disease can be both prevented and reversed. In Never Be Sick Again, Francis presents a seminal work based on these findings - a revolutionary theory of health and disease: there is only one disease (malfunctioning cells), only two causes of...
	Magic Cancer Bullet: How a Tiny Orange Pill May Rewrite Medical History by Daniel Vasella (Author), Robert Slater (Author) Tells the remarkable story behind the revolutionary miracle cure for cancer, Gleevec, and describes its development by pharmaceutical company, Novartis.
	The Thyroid Cancer Book by M. Sara Rosenthal Ph.D. (Author) Now in its second edition, the only consumer book on thyroid cancer in plain language, also contains a Low Iodine Cookbook. Recommended by Johns Hopkins Thyroid Tumor Center, The Thyroid Foundation of America, The American Foundation for Thyroid Patients, The Thyroid Foundation of Canada, CancerHelpUK, and thyroid cancer patients from both Thyca and Thry'Vors.
	The Gene Makeover: The 21st Century Anti-Aging Breakthrough by Vincent C. Giampapa (Author), Frederick F. Buechel (Author), Ohan Karatoprak (Author) You know how victims and perpetrators are identified by their DNA on TV shows like "CSI" and "Law & Order." Now, that same science can help you lead a longer, healthier life. DNA-deoxyribonulceic acid-is the chemical inside your cells that carries the genetic instructions that make you unique. Aging occurs in DNA as cells replicate themselves continually in a process similar to photocopying. As the normal functioning of our cells becomes less efficient over time due to environmental, lifetyle and hereditary factors, those cells produce less accurate copies, causing malfunctioning throughout the body that results in degenerative diseases and aging. Thanks to the latest advances in genetic science, you no longer have to be a victim of your genetic inheritance. Dr. Giampapa and other...